Adams Street Partners — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.
BiotechHealthtechRadnor, US
Eric Warren(Chief Commercial Officer)inAlex Gold(Chief Medical Officer)inAdam Levy(Executive Officer)Alexander Asam(Director)
BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)Olivier Litzka(Director)in
Co-investorsAndera PartnersSamsara BioCapitalSR One Capital ManagementYsios CapitalBoulder VenturesCatalys Pacific+1 more
Dremio provides an Agentic Lakehouse platform that enables fast, governed access to enterprise data across multiple sources without ETL, with an AI Semantic Layer for business context and autonomous infrastructure management.
AI & Machine LearningData & InfrastructureEnterprise Software
Tomer Shiran(Founder)inSendur Sellakumar(CEO)in
Co-investorsSapphire VenturesInsight PartnersRedpoint VenturesAlpha Square GroupCisco InvestmentsDTCP+5 more
Remote helps companies hire, pay, and manage employees internationally by removing barriers to cross-border employment.
Future of WorkHR TechSaaS
Marcelo Lebre(Co-founder & President)inJob van der Voort(Co-founder & CEO)in
Co-investorsAccelB Capital GroupB4 CapitalBase PartnersCategory VenturesDaft Capital+11 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.